B RILEY FINANCIAL INC - RILY 6 1/2 09/30/26 (RILYN)

US05580M8010

11.87  +0.52 (+4.63%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RILYN. RILYN was compared to 222 industry peers in the Capital Markets industry. RILYN has a bad profitability rating. Also its financial health evaluation is rather negative. RILYN is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year RILYN has reported negative net income.
In the past year RILYN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: RILYN reported negative net income in multiple years.
Of the past 5 years RILYN 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -3.49%, RILYN is not doing good in the industry: 88.02% of the companies in the same industry are doing better.
RILYN has a worse Return On Equity (-76.26%) than 93.55% of its industry peers.
RILYN's Return On Invested Capital of 1.95% is on the low side compared to the rest of the industry. RILYN is outperformed by 69.59% of its industry peers.
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROIC 1.95%
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RILYN has a worse Operating Margin (8.23%) than 75.58% of its industry peers.
In the last couple of years the Operating Margin of RILYN has declined.
RILYN's Gross Margin of 67.58% is fine compared to the rest of the industry. RILYN outperforms 68.20% of its industry peers.
RILYN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.23%
PM (TTM) N/A
GM 67.58%
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%

0

2. Health

2.1 Basic Checks

The number of shares outstanding for RILYN has been increased compared to 1 year ago.
The number of shares outstanding for RILYN has been increased compared to 5 years ago.
RILYN has a worse debt/assets ratio than last year.

2.2 Solvency

RILYN has an Altman-Z score of -0.15. This is a bad value and indicates that RILYN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.15, RILYN is not doing good in the industry: 81.57% of the companies in the same industry are doing better.
RILYN has a debt to FCF ratio of 42.28. This is a negative value and a sign of low solvency as RILYN would need 42.28 years to pay back of all of its debts.
RILYN's Debt to FCF ratio of 42.28 is in line compared to the rest of the industry. RILYN outperforms 40.55% of its industry peers.
A Debt/Equity ratio of 18.53 is on the high side and indicates that RILYN has dependencies on debt financing.
The Debt to Equity ratio of RILYN (18.53) is worse than 95.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF 42.28
Altman-Z -0.15
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

RILYN has a Current Ratio of 0.22. This is a bad value and indicates that RILYN is not financially healthy enough and could expect problems in meeting its short term obligations.
RILYN has a Current ratio of 0.22. This is amonst the worse of the industry: RILYN underperforms 85.71% of its industry peers.
A Quick Ratio of 0.18 indicates that RILYN may have some problems paying its short term obligations.
RILYN's Quick ratio of 0.18 is on the low side compared to the rest of the industry. RILYN is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.18

3

3. Growth

3.1 Past

RILYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.84%.
Looking at the last year, RILYN shows a very strong growth in Revenue. The Revenue has grown by 31.31%.
The Revenue has been growing by 28.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-434.63%
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-15.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RILYN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

RILYN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. RILYN is cheaper than 77.42% of the companies in the same industry.
RILYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RILYN is cheaper than 86.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.59
EV/EBITDA 14.39

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 43.38%, RILYN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 9.70, RILYN pays a better dividend. On top of this RILYN pays more dividend than 98.62% of the companies listed in the same industry.
RILYN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 43.38%

5.2 History

The dividend of RILYN is nicely growing with an annual growth rate of 43.04%!
RILYN has been paying a dividend for over 5 years, so it has already some track record.
RILYN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)43.04%
Div Incr Years0
Div Non Decr Years3

5.3 Sustainability

RILYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-67.91%
EPS Next 2YN/A
EPS Next 3YN/A

B RILEY FINANCIAL INC - RILY 6 1/2 09/30/26

NASDAQ:RILYN (1/14/2025, 8:02:47 PM)

11.87

+0.52 (+4.63%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-25 2024-11-25/amc
Earnings (Next)N/A N/A
Inst Owners34.83%
Inst Owner ChangeN/A
Ins Owners35.46%
Ins Owner ChangeN/A
Market Cap359.66M
Analysts0
Price TargetN/A
Short Float %1.69%
Short Ratio8.02
Dividend
Industry RankSector Rank
Dividend Yield 43.38%
Dividend Growth(5Y)43.04%
DP-67.91%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-15 2025-01-15 (0.40625)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF 3.59
P/OCF 3.35
P/B 1.57
P/tB N/A
EV/EBITDA 14.39
EPS(TTM)-3.61
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.3
FCFY27.84%
OCF(TTM)3.54
OCFY29.82%
SpS45.9
BVpS7.54
TBVpS-18.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROCE 4.46%
ROIC 1.95%
ROICexc 2.03%
ROICexgc 2.5%
OM 8.23%
PM (TTM) N/A
GM 67.58%
FCFM 7.2%
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-40.96%
ROICexcg growth 5Y-5.6%
ROICexc growth 3Y-40.01%
ROICexc growth 5Y-4.61%
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF 42.28
Debt/EBITDA 26.11
Cap/Depr 14.91%
Cap/Sales 0.51%
Interest Coverage 0.36
Cash Conversion 66.13%
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.18
Altman-Z -0.15
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9.33%
Cap/Depr(5y)11.35%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-434.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-15.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14211.5%
EBIT growth 3Y-18.25%
EBIT growth 5Y22.01%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.18%
FCF growth 3Y-32.92%
FCF growth 5YN/A
OCF growth 1Y35.95%
OCF growth 3Y-24.83%
OCF growth 5YN/A